Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02062671

Enrollment

Registered

2014-02-14

Start date

2014-02-28

Completion date

2015-02-28

Last updated

2014-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Polycystic Kidney Disease

Keywords

ADPKD, denervation, renal denervation

Brief summary

In patients with polycystic kidney disease, pain may be resistant to drug therapy and may reduce quality of life. This study investigate the effect of renal denervation on this pain.

Interventions

PROCEDURErenal denervation

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Pain limiting daily activities in spite of pain killers, ADPKD

Exclusion criteria

* Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Pain	6 months	Pain from VAS

Secondary

Measure	Time frame	Description
Quality of Life (QoL)	6 months	SF-12v2

Other

Measure	Time frame	Description
kidney function	6 months	creatinine clearance

Countries

Denmark

Contacts

Primary ContactHans Dieperink, MD

hans.dieperink@rsyd.dk+4520598851

Backup ContactMarie Blicher, MD

marie.blicher@rsyd.dk+ 45 65415305

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026